ACADIA PHARMACEUTICALS INC. Effective Tax Rate
ACADIA PHARMACEUTICALS INC. (ACAD) reported Effective Tax Rate of 32.20% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-05
- ACADIA PHARMACEUTICALS INC. effective income tax rate reconciliation, percent for the quarter ending 2026-06-30 was 32.20%, a 4.45% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. effective income tax rate reconciliation, percent for the quarter ending 2026-03-31 was 8.60%.
- ACADIA PHARMACEUTICALS INC. effective income tax rate reconciliation, percent for the quarter ending 2025-06-30 was 33.70%.
- ACADIA PHARMACEUTICALS INC. effective income tax rate reconciliation, percent for fiscal 2025 was -181.48%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|
| 2026-06-30 | 32.20% 10-Q · filed 2026-08-05 | 30.40% 10-Q · filed 2026-08-05 | |
| 2026-03-31 | 8.60% 10-Q · filed 2026-05-07 | ||
| 2025-12-31 | -181.48% 10-K · filed 2026-02-26 | ||
| 2025-06-30 | 33.70% 10-Q · filed 2026-08-05 | 32.90% 10-Q · filed 2026-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |